Trial Profile
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Novel Subcutaneous Depot Formulation of Buprenorphine (INDV-6200) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Mar 2019
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary) ; Buprenorphine; Naltrexone
- Indications Opioid-related disorders
- Focus Pharmacokinetics
- Sponsors Indivior
- 30 Oct 2018 New trial record